Pacific RxTracts - March 2025

Articles Naloxone Extended-Release System Discovered at the University of the Pacific FDA Approval for Unresectable/ Metastatic Breast Cancer Journavx (Suzetrigine): A New Era in Pain Management New Treatment Approved for Congenital Adrenal Hyperplasia Optimal DAPT Strategy? A Promising Approach for Post-PCI Care Benefit of SGLT2 Inhibitors in Preventing Contrast-Induced Kidney Injury Dark Chocolate and Type 2 Diabetes: A Sweet Connection? Confirming Palbociclib’s Safety in Liver Impaired Patients Aztreonam-avibactam, a Promising Therapeutic for Gram-Negative Bacterial Infections The Future is Now: LBP-EC01, a Genetically Enhanced Bacteriophage for UTIs The Safety and Efficacy Profiles of Short-Term Duration Oral Regimens for Rifampin-Resistant TB A New Boxed Warning for Glatiramer Acetate Clozapine: From Last Resort to Second-Line Therapy? Esketamine (Spravato CIII) Receives FDA Approval as First Monotherapy Treatment for Treatment-Resistant Depression Evaluation of the Impacts of Cannabis Use on Brain Function